Efficacy and safety of repeated transcranial magnetic stimulation combined with escitalopram in the treatment of major depressive disorder: a meta-analysis
ConclusionOur findings suggest that rTMS combined with escitalopram can benefit patients with MDD in a safe manner, which may help in guiding clinical practice.Systematic review registrationDOI number: 10.37766/inplasy2023.11.0114, INPLASY2023110114.
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
More News: China Health | Databases & Libraries | Depression | Lexapro | Psychiatry | Science | Study